Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

Université du Québec à Montréal

$35,000.00

Advanced bioanalytical mass spectrometry methods for investigating the mechanism of protein binding by reactive metabolites

FY 2012-13

Summary
The main role of drug metabolism is to detoxify the body from xenobiotics, rendering them more polar and thus more easily cleared. Some drugs, however, are bioactivated into reactive metabolites with the potential to covalently bind to proteins. These reactive metabolites can bind to proteins in vivo and cause administration of these drugs to be potentially very dangerous. The goal of our research program is to design new innovative methods to study these toxic interactions. Our focus is to devise a strategy to further understand binding of reactive metabolites to proteins using a combination of modern mass spectrometry tools for studying both small molecules and proteins. Advanced liquid chromatography-mass spectrometry (LC-MS) instrumentation, together with sophisticated data processing tools, will be utilized for the structural elucidation of reactive metabolites and modified proteins. The proposed research program involves the identification of modifications sites on proteins known to be in vivo protein targets of reactive metabolites. Our original approach based on innovative analytical methods including affinity purification of protein targets and selective filtering of mass spectral data. A promising avenue we are currently pursuing for identifying protein targets in complex samples is using drug alkyne analogs for labeling modified proteins followed by tagging and selective purification using click chemistry. We will also be employing stable-isotope labeled drugs to selectively filter complex MS data for specific isotope patterns. Once protein targets are identified, adduct formation will be studied under different conditions in order to better understand the mechanism of protein covalent binding by reactive metabolites. Novel strategies will be devised for studying the mechanisms of protein binding to reactive drug metabolites. A systematic approach will be taken to identify important protein targets and their modification sites as well as elucidate the mechanism of binding. This research should have very important consequences for better understanding drug metabolism and bioactivation as well as idiosyncratic drug reactions (IDRs).
Program
Discovery Grants Program - Individual
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
355933-2011
Name nom
Sleno, Lekha
Department département
Chimie
Organization id
57
Institution établissement
Université du Québec à Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2011
Award amount
35000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
2
Nb partie
5
Application title
Advanced bioanalytical mass spectrometry methods for investigating the mechanism of protein binding by reactive metabolites
Keyword
NSERC
Application summary
The main role of drug metabolism is to detoxify the body from xenobiotics, rendering them more polar and thus more easily cleared. Some drugs, however, are bioactivated into reactive metabolites with the potential to covalently bind to proteins. These reactive metabolites can bind to proteins in vivo and cause administration of these drugs to be potentially very dangerous. The goal of our research program is to design new innovative methods to study these toxic interactions. Our focus is to devise a strategy to further understand binding of reactive metabolites to proteins using a combination of modern mass spectrometry tools for studying both small molecules and proteins. Advanced liquid chromatography-mass spectrometry (LC-MS) instrumentation, together with sophisticated data processing tools, will be utilized for the structural elucidation of reactive metabolites and modified proteins. The proposed research program involves the identification of modifications sites on proteins known to be in vivo protein targets of reactive metabolites. Our original approach based on innovative analytical methods including affinity purification of protein targets and selective filtering of mass spectral data. A promising avenue we are currently pursuing for identifying protein targets in complex samples is using drug alkyne analogs for labeling modified proteins followed by tagging and selective purification using click chemistry. We will also be employing stable-isotope labeled drugs to selectively filter complex MS data for specific isotope patterns. Once protein targets are identified, adduct formation will be studied under different conditions in order to better understand the mechanism of protein covalent binding by reactive metabolites. Novel strategies will be devised for studying the mechanisms of protein binding to reactive drug metabolites. A systematic approach will be taken to identify important protein targets and their modification sites as well as elucidate the mechanism of binding. This research should have very important consequences for better understanding drug metabolism and bioactivation as well as idiosyncratic drug reactions (IDRs).
Université du Québec à Montréal - $35,000 Grant (2012… | Canada Spends